1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25 | Licensing Program Analyst (LPA) Angel Ascencio conducted a Case Management - Deficiency visit to the above facility. LPA Ascencio met with Quality Assurance Specialist (QA) Elizabeth Monarrez at 10:45 a.m. Interim Administrator Rafael Silva arrived shortly after.
During today's visit, a medication audit was conducted starting at 11:25 a.m. LPA Ascencio observed the Centrally Stored Medication Record for Resident #1 (R1) and did not observe Olanzapine 10 mg, Clozapine 50 mg, and Clorazapine 100 mg centrally stored. Staff #1 (1) stated R1 was switched over to a new medication the previous week and was not included on the routine medication list. Because of this change, the pharmacy sent R1 medication "off-cycle", and was not included on the centrally stored medication. S1 added that they will add the three (3) medications to the centrally stored.
1 citation was observed during today’s visit.
Pursuant to Title 22 Division 6 Chapter 8 of the CA Code of Regulations, the following deficiencies were cited
(refer to LIC 809-D).
A copy of this report and appeal rights were provided to Administrator Silva. |